Press release
McGuff Pharmaceuticals, Inc. Achieves FDA Approval of New Facility
New Facility Allows for Greater Capacity of Pharmaceutical Manufacturing in the U.S.
Ronald M. McGuff, President of MPI, has been committed to making this a reality. The FDA approval is the result of the dedicated efforts of its employees to acquire, design, construct and validate. It marks another milestone for the company and creates new business opportunities in both the Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO) marketplaces.
As a CMO/CDMO, MPI helps pharmaceutical companies bring new products or formulas to market without investing in additional infrastructure to support it. MPI provides end-to-end, fully integrated drug development and manufacturing solutions and services, including formulation development, product stability, regulatory compliance, clinical trials, quality assurance, and more.
This new facility is designed to meet customer demand for:
- MPI NDA and ANDA labeled injectable products
- Contract manufactured products
- Clinical trial products
"With this approval, we will increase our production of ASCOR®, our FDA-approved Ascorbic Acid Injection (vitamin C injection), ensuring that we meet the growing demands of our customers, both nationally and internationally," said McGuff. "I wish to extend my heartfelt gratitude to everyone involved in this project for their hard work and commitment. Our employees' efforts have made this achievement possible, and I am excited about the future it brings."
Highlights of the MPI Facility
- Address: 4040 West Carriage Drive, Santa Ana, Calif., 92704
- 86,000 square foot plant
- Sterile fill-and-finish pharmaceutical manufacturing
- Compounding for solutions, emulsions and suspensions
- Current Good Manufacturing Practices (cGMP)
- Sterile and hazardous drugs in 5mL through 100mL vials
- Developed to manufacture high-quality sterile pharmaceuticals in small and large quantities using isolator technology
- Significant Utility capability
- Analytical testing capability
-DSCSA-compliant packaging line
Press Contact:
Trevor McGuff, Director of Corporate Operations
McGuff Company, Inc.
3524 West Lake Center Dr.
Santa Ana, CA 92704
(800) 854-7220
marketinggroup@mcguff.com
About McGuff Pharmaceuticals, Inc.
McGuff Pharmaceuticals, Inc. (MPI), a division of McGuff Company, Inc. is a family and veteran-owned company based in Santa Ana, Calif. It is an FDA-approved sterile fill manufacturer that maintains a tradition of quality and core competency with current Good Manufacturing Practices.
The McGuff Family of Companies has an over 50-year history of excellence in the pharmaceutical and medical product markets.
About ASCOR® (Ascorbic Acid Injection, USP)
ASCOR® is McGuff Pharmaceuticals Inc.'s branded formula of ascorbic acid injection, USP and is the only FDA-approved formula on the market.
Learn more: www.mcguffpharmaceuticals.com | www.mcguff.com/ASCOR
(800) 854-7220 | pharmaceuticalanswers@mcguff.com.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release McGuff Pharmaceuticals, Inc. Achieves FDA Approval of New Facility here
News-ID: 3731715 • Views: …
More Releases for Pharmaceutical
Metronidazole Market 2023 Latest Innovations and Outlook By Players - Hongyuan P …
The Metronidazole Market 2023 study focuses on a global evaluation of information from the most recent market developments. The purpose of MarketsandResearch.biz is to offer the company's customers a comprehensive market overview to formulate development plans.
Designing of the report is done with the help of infographics, charts, and graphs. The report initially analyzes the various segments of the global Metronidazole market in a brief manner, which includes product types, applications.…
Hyperthyroidism Treatment Market Analytical Overview and Future | Merck, Herbran …
The Hyperthyroidism Treatment market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with development…
Mevastatin Market Is Booming Worldwide |Zhejiang Hisun Pharmaceutical, Guangdong …
Global Mevastatin Market Size research report 2022 offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. This study provides information about the sales and revenue during the historic and forecasted period of (2022 to 2028). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for…
Global Specialty Pharmaceutical Market Driving Future Growth on Specialty Pharma …
Global Specialty Pharmaceutical Industry Synopsis:
The Specialty Pharmaceutical Market report provides a detailed analysis of this business space. The market is analyzed in terms of production as well as consumption. Based on the production aspect, the report includes particulars pertaining to the manufacturing processes of the product, alongside revenue and gross margins of the respective manufacturers.
The Global Specialty Pharmaceutical Market will reach xxx Million USD in 2020 with CAGR xx%…
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles – Hongyua …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in…
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in North…
